Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001–2017

Journal Article · · Preventive Medicine
 [1];  [1];  [2];  [3]
  1. Centers for Disease Control and Prevention, Atlanta, GA (United States); Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
  2. Adventist Health White Memorial Medical Center, Los Angeles, CA (United States)
  3. Centers for Disease Control and Prevention, Atlanta, GA (United States)
Vulvar cancer incidence has been rising in recent years, possibly due to increasing exposure to human papillomavirus (HPV). We assessed incidence rates of HPV-associated and non-HPV-associated vulvar cancers diagnosed from 2001 to 2017 in the United States (US). Using population-based cancer registry data covering 99% of the US population, incidence rates were calculated and stratified by age, race/ethnicity, stage, geographic region, and histology. The average annual percent change in incidence per year were calculated using joinpoint regression. From 2001 to 2017, the incidence of HPV-associated vulvar cancers increased by 1.2% per year, most notably among women who were aged 50–59 years (2.6%), 60–69 years (2.4%), and ≥ 70 years (0.9%); of White (1.5%) and Black (1.1%) race; diagnosed at an early (1.3%) and late (1.8%) stage; and living in the Midwest (1.9%), Northeast (1.4%), and South (1.2%). Incidence increased each year for HPV-associated histologic subtypes including keratinizing (4.7%), non-keratinizing (6.0%), and basaloid (3.1%) squamous cell carcinomas (SCCs), while decreases were found in warty (2.7%) and microinvasive (5.5%) SCCs. HPV-associated vulvar cancer incidence increased overall and among women aged over 50 years while remaining stable among women younger than 50 years. Furthermore, the overall incidence for non-HPV-associated cancers was stable. Continued surveillance of HPV-associated cancers will allow us to monitor future trends as HPV vaccination coverage increases in the US.
Research Organization:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE; USDOE Office of Science (SC)
Grant/Contract Number:
SC0014664
OSTI ID:
2425830
Alternate ID(s):
OSTI ID: 1962920
Journal Information:
Preventive Medicine, Journal Name: Preventive Medicine Journal Issue: C Vol. 164; ISSN 0091-7435
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (24)

Permutation tests for joinpoint regression with applications to cancer rates journal February 2000
Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva journal June 2017
Vulvar cancer in high‐income countries: Increasing burden of disease journal August 2017
Geographic and temporal variations in the incidence of vulvar and vaginal cancers journal July 2020
High-Grade Vulvar, Vaginal, and Anal Precancers Among U.S. Adolescents and Young Adults After Human Papillomavirus Vaccine Introduction journal January 2022
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva journal November 2013
Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma journal May 2020
Biological relevance of human papillomaviruses in vulvar cancer journal April 2017
A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica journal June 2005
A Cohort Effect of the Sexual Revolution May Be Masking an Increase in Human Papillomavirus Detection at Menopause in the United States journal January 2013
Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas journal April 2010
Delay in diagnosis and increasing incidence of vulvar cancer: a root cause analysis journal February 2021
Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia Since 1982 journal November 2015
Prevalence of Human Papillomavirus Types in Invasive Vulvar Cancers and Vulvar Intraepithelial Neoplasia 3 in the United States Before Vaccine Introduction journal October 2012
Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years journal December 2010
Incidence Patterns and Temporal Trends of Invasive Nonmelanotic Vulvar Tumors in Germany 1999-2011. A Population-Based Cancer Registry Analysis journal May 2015
Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015 journal August 2018
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices journal August 2019
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018 journal March 2021
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020 journal September 2021
Surveillance of Vaccination Coverage Among Adult Populations —United States, 2018 journal May 2021
Racial Misclassification of American Indians and Alaska Natives by Indian Health Service Contract Health Service Delivery Area journal June 2014
Vulvar cancer: epidemiology, clinical presentation, and management options journal March 2015
Evaluation of the Vulvar Cancer Histology Code Reported by Central Cancer Registries: Importance in Epidemiology journal October 2016